Partnerstwa akademickie (business-academia) - rola uniwersytetów i instytucji naukowych w rozwoju współpracy w sektorze biofarmaceutycznym

• Autorzy: Łukasz Puślecki

Warianty tytułu

Business Alliances - the Role of Universities and Scientific Institutions in the Development of Cooperation of Biopharmaceutical Sector

• Języki publikacji: PL

Abstrakty

Celem artykułu jest ocena możliwości rozwoju współczesnych partnerstw akademickich (business-academia) i ich wpływu na rozwój współpracy w sektorze biofarmaceutycznym w oparciu o najnowsze dane uzyskane z ASAP (Association of Strategic Alliance Professionals). Zaprezentowane zostaną przykłady współpracy firm, uniwersytetów i instytutów badawczych, a także możliwe formy pozyskiwania innowacji przez firmy z uniwersytetów i instytutów badawczych w ramach modelu otwartych innowacji.(abstrakt oryginalny)

EN

The aim of this article is to review the development of modern business-academia Alliance and their impact on the development of cooperation in the biopharmaceutical sector based on the latest data from the Association of Strategic Alliance Professionals (ASAP). Examples of cooperation between companies, universities and research institutes will be presented, as well as possible ways of gaining innovation by companies from universities and research institutes in the model of open innovation.(original abstract)

Słowa kluczowe

PL

Przedsiębiorstwo farmaceutyczne; Przemysł farmaceutyczny; Innowacje; Współpraca uczelni z przedsiębiorstwami; Przemysł biofarmaceutyczny

EN

Pharmaceutical company; Pharmaceutical industry; Innovations; University-Business Cooperation (UBC); Biopharma industry

• Czasopismo: Prace Naukowe Uniwersytetu Ekonomicznego we Wrocławiu
• Rocznik: 2017
• Numer: nr 499 Nauki ekonomiczne w XXI wieku - wyzwania, dylematy, perspektywy. Ekonomia, finanse, nauki o zarządzaniu
• Strony: 213--222

Twórcy

autor

Łukasz Puślecki

• Uniwersytet Ekonomiczny w Poznaniu

Bibliografia

• Agrawal A., 2006, Engaging the inventor: Exploring licensing strategies for university inventions and the role of latent knowledge, Strategic Management Journal, 27(1), s. 63-79.
• Arundel A., Geuna A., 2004, Proximity and the use of public science by innovative European firms, Economics of Innovation and New Technology, 13(6), s. 559-580.
• Bruneel J., D'Este P., Salter A., 2010, Investigating the factors that diminish the barriers to university- -industry collaboration, Research Policy, 39(7), s. 858-868.
• Chesbrough H., Bogers M., 2014, Explicating Open Innovation: Clarifying an Emerging Paradigm for Understanding Innovation, [w:] Open Innovation: New Frontiers and Applications, red. H. Chesbrough, W. Vanhaverbeke, J. West, Oxford University Press, Oxford.
• Contractor F.J., Lorange P. (red.), 2002, Cooperative Strategies and Alliances, Elsevier Science Ltd. Culpan R. (red.), 2014, Open Innovation Through Strategic Alliance, Palgrave MacMillan, New York.
• D'Este P., Perkmann M., 2011, Why do academics engage with industry? The entrepreneurial university and individual motivations, Journal of Technology Transfer, 36(3), s. 316-339.
• DeWitt J., 2017, Common ground for research, Strategic Alliance Magazine, Association of Strategic Alliance Professionals, Q3, s. 27-28.
• DeWitt J., Burke M., 2012, Alliances that could save the world, Strategic Alliance Magazine, Association of Strategic Alliance Professionals, Q4, s. 36-41.
• DeWitt J., Burke M., 2013, Next wave, Strategic Alliance Magazine, Association of Strategic Alliance Professionals, Q3, s. 18-23.
• Duysters G., Hagedoorn J., 2000, A note on organizational modes of strategic technology partnering, Journal of Scientific & Industrial Research, vol. 58, s. 640-649.
• Elsevier, 2017, https://www.elsevier.com/connect/building-successful-partnerships-between-academia- and-industry (dostęp 20.09.2017).
• Fraser R.L., 2014, Altruistic alliances: Business thrives when biopharma companies partner with nonprofits, Strategic Alliance Magazine, Association of Strategic Alliance Professionals, Q3, s. 22-28, 41.
• Gautier T.J., 2014, Consortia and ecosystems developments in life sciences: Advances partnering addresses global healthcare issues, Strategic Alliance Magazine, Association of Strategic Alliance Professionals, Q3, s. 30-35.
• George G., Zahra S.A., Wood D.R., 2002, The effects of business-university alliances on innovative output and financial performance: A study of publicly traded biotechnology companies, Journal of Business Venturing 17(6), s. 577-609.
• Gomes-Casseres B., 2014, Creating joint value: in biopharma and many other industries,"not invented here" is SO last century, Strategic Alliance Magazine, Association of Strategic Alliance Professionals, Q3, s. 36-41.
• Gulati R., Singh H., 1998, The architecture of cooperation: Managing coordination cost and appropriation concerns in strategic alliances, Administrative Science Quarterly. 43(4), s. 781-814.
• Hagedoorn J., 2002, Inter-firm R&D partnerships: An overview of major trends and patterns since 1960, Research Policy, 31 (4), s. 477-492.
• Hagedoorn J., Osborn, R.N., 2002, Interfirm R&D Partnerships: Major Theories and Trends since 1960, [w:] Contractor F.J., Lorange P. (red.), Cooperative Strategies and Alliances, Elsevier Science Ltd.
• Hanson C., 2014, Partnering is key to the future of our company, Strategic Alliance Magazine, Association of Strategic Alliance Professionals, Q4, s. 18-23.
• Hanson C., 2015, Orchestrating partnering - across enterprise and ecosystems. How alliance management can adapt and lead as high tech (and other industries) dive into the life sciences and healthcare ecosystem, Strategic Alliance Magazine, Association of Strategic Alliance Professionals, Q3, s. 14-20.
• Hanson C., 2016, Bringing academia aboard the enterprise, Strategic Alliance Magazine, Association of Strategic Alliance Professionals, Fall 2016, s. 17-21.
• Hennart J.F., 1998, A transaction cost theory of equity joint ventures, Strategic Management Journal, 9, s. 361-374.
• Hess A.M., Rothaermel F.T., 2011, When are assets complementary? Star scientists, strategic alliances, and innovation in the pharmaceutical industry, Strategic Management Journal, 32, s. 895-909.
• Perkmann M., West J., 2014, Open science and Open Innovation: Sourcing Knowledge from Universities, [w:] Link A.N., Siegel D.S., Wright M. (red.), The Chicago Handbook of University Technology Transfer and Academic Entrepreneurship, University of Chicago Press, Chicago.
• Puślecki Ł., 2010, Wpływ współpracy technologicznej krajów rozwiniętych gospodarczo na ich konkurencyjność międzynarodową, Wydawnictwo GRADO, Toruń.
• Puślecki Ł., 2015, The development and management of alliance networks in the biopharmaceutical industry, [w:] Hittmar S., Sroka W. (red.), Management of Network Organizations: Theoretical Problems and the Dilemmas in Practice, Springer International Publishing.
• Puślecki Ł., 2016, Development of modes of cooperation: An opportunity for open innovation alliances in Polish biopharmaceutical industry, Management, vol. 11, no. 1, s. 67-80.
• Puślecki Ł., Staszków M., 2015, New cooperation modes: An opportunity for Polish biotechnological clusters, Managing Global Transitions, vol. 13, no. 2, s. 171-188.
• Santarek K. (red), 2008, Transfer technologii z uczelni do biznesu. Tworzenie mechanizmów transferu technologii, PARP, Warszawa.
• Scitechstrategy, 2016, http://scitechstrategy.com/2016/03/hidden-risks-for-pharmas-in-rd-partnerships/ (dostęp 20.09.2017).
• Wessmer U., Dussauge P., 2011, Network resource stocks and flows: How do alliance portfolios affect the value of new alliance formations?, Strategic Management Journal, 32, s. 871-883.
• West J., 2014, Open Innovation: Learning from Alliance Research, [w:] Culpan R. (red.), Open Innovation Through Strategic Alliances, Palgrave MacMillan, New York.
• Wilks Ch., Prothmann Ch., 2012, Open innovation alliances, novel alliance models accelerate the identification and advancement of breakthrough therapies, Strategic Alliance Magazine, Association of Strategic Alliance Professionals, Q4, s. 42-45.

Identyfikatory

DOI

10.15611/pn.2017.499.20